☆ 4.5 Article

Systemic embolism in amyloid transthyretin cardiomyopathy

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis

Francesco Bandera et al.

Summary: This study characterized left atrial pathology in explanted hearts with transthyretin amyloid cardiomyopathy (ATTR-CM); assessed left atrial mechanics using echocardiographic speckle tracking in a large cohort of ATTR-CM patients; and studied the association with mortality. The findings revealed extensive atrial infiltration of ATTR amyloid, loss of atrial function, and increased stiffness, which were strong independent predictors of mortality. A distinctive phenotype named atrial electromechanical dissociation (AEMD) was identified in patients in sinus rhythm with poor prognosis.

JACC-CARDIOVASCULAR IMAGING (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding

Lindsey R. Mitrani et al.

Summary: The study found that patients with ATTR-CA and AF are at increased risk for stroke compared to those without AF. There was no significant difference in primary outcomes between AF patients treated with warfarin and NOACs, with similar rates of thrombotic events and major bleeds observed.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation

Francesco Cappelli et al.

Summary: In a large multicentric cohort of CA patients, the prevalence and incidence rate of AEs was high, with a significant proportion of events occurring despite anticoagulation therapy or in patients in sinus rhythm. A higher CHA2DS2-VASc score may identify patients at risk of AEs, even among those in sinus rhythm.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Persistence of Left Atrial Appendage Thrombus in Patients With Cardiac Amyloidosis

Edward A. El-Am et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious infiltrative disease caused by the deposition of amyloid fibrils in the heart, which can be due to genetic variants or acquired conditions. With advances in imaging techniques, non-invasive diagnosis is now possible, showing that cardiac amyloidosis is more common than previously thought. The Working Group on Myocardial and Pericardial Disease has proposed definitions and diagnostic algorithms for cardiac amyloidosis.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans

Masatoshi Minamisawa et al.

Summary: This study showed that carriers of the V122I TTR variant in African-Americans have significant left atrial enlargement and dysfunction compared to non-carriers, suggesting that abnormalities in left atrial function may be early markers of subclinical disease in this population.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans

Senthil Selvaraj et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

Eve Cariou et al.

Summary: In patients with cardiac amyloidosis, there are differences in clinical characteristics and outcomes between those receiving DOAC and VKA anticoagulation therapy, with DOACs appearing to be at least as effective and safe as VKAs.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious and progressive infiltrative disease caused by amyloid fibril deposition in the heart. Advances in imaging techniques and diagnostic algorithms have made it possible to diagnose the condition non-invasively. Monitoring and treating cardiac amyloidosis are important in bridging the gap between research advances and clinical practice.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Transthyretin Cardiac Amyloidosis Predictors, Prevalence, and Efficacy of Rhythm Control Strategies

Eoin Donnellan et al.

JACC-CLINICAL ELECTROPHYSIOLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Management of Arrhythmias in Cardiac Amyloidosis

Shaun Giancaterino et al.

JACC-CLINICAL ELECTROPHYSIOLOGY (2020)

Add to Collection

Letter Cardiac & Cardiovascular Systems

High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis

Ana Martinez-Naharro et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization

Sharmila Dorbala et al.

JOURNAL OF NUCLEAR CARDIOLOGY (2019)

Add to Collection

Letter Cardiac & Cardiovascular Systems

No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis

Eoin Donnellan et al.

JACC-CLINICAL ELECTROPHYSIOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Mathew S. Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disprovingmyths

Esther Gonzalez-Lopez et al.

EUROPEAN HEART JOURNAL (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin A Prospective, Observational Cohort Study

Lawreen H. Connors et al.

CIRCULATION (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore et al.

CIRCULATION (2016)

Add to Collection

Review Cardiac & Cardiovascular Systems

Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review

Oliver P. Guttmann et al.

HEART (2014)

Add to Collection

Article Critical Care Medicine

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation

Gregory Y. H. Lip et al.

CHEST (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis

DaLi Feng et al.

CIRCULATION (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Intracardiac thrombosis and embolism in patients with cardiac amyloidosis

DaLi Feng et al.

CIRCULATION (2007)

Add to Collection

Article Cardiac & Cardiovascular Systems

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy

E Perugini et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.